Approval · Notice of Compliance 15607 · 2014
NAPROXEN: Notice of Compliance 15607
Issued May 15, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15607
- Date
- May 15, 2014
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Non-steroidal anti-inflammatory drug (nsaid)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROXEN | 02350750 | Cancelled Post Market |
| NAPROXEN | 02350769 | Cancelled Post Market |
| NAPROXEN | 02350777 | Cancelled Post Market |
| NAPROXEN EC | 02350785 | Cancelled Post Market |
| NAPROXEN EC | 02350793 | Cancelled Post Market |
| NAPROXEN EC | 02350807 | Cancelled Post Market |